Related Experiment Videos
Athina Markou's contributions to treatment development for mental illnesses: a perspective
1Division of Neuroscience and Basic Behavioral Neuroscience, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, 20892, USA.
Psychopharmacology
|November 25, 2016
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.
Science translational medicine·2025
Biomarker Methodologies: A NIMH Perspective.
Advances in neurobiology·2024
NIMH perspectives on future directions in neuroimaging for mental health.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2024
New directions in psychiatric drug development: promising therapeutics in the pipeline.
Expert opinion on drug discovery·2023
Priorities in stress research: a view from the U.S. National Institute of Mental Health.
Stress (Amsterdam, Netherlands)·2020
Trends in cannabis use disorder among adults in the United States, 2021-2024.
Addictive behaviors·2026
Post-traumatic stress disorder (PTSD) in war: a comprehensive review of subtypes, risk and protective factors, and therapeutic approaches.
Journal of psychiatric research·2026
The path from delay to dropout: A mediation analysis of how treatment settings explain the impact of wait time on treatment completion in substance use disorder programs.
International journal of medical informatics·2026